The high occurrence of prostate cancer and the implication of the AR signaling in its growth [124,138] resulted in the need to find drugs able to sustain most of the anabolic and protein-protective functions of T because of the limited (or counterproductive) benefits of T deprivation [139,140,141,142]. The gene discussed is AR; the disease is prostate cancer.